Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 135

1.

Anti-Mullerian-hormone-dependent regulation of the brain serine-protease inhibitor neuroserpin.

Lebeurrier N, Launay S, Macrez R, Maubert E, Legros H, Leclerc A, Jamin SP, Picard JY, Marret S, Laudenbach V, Berger P, Sonderegger P, Ali C, di Clemente N, Vivien D.

J Cell Sci. 2008 Oct 15;121(Pt 20):3357-65. doi: 10.1242/jcs.031872. Epub 2008 Sep 16.

2.

Transforming growth factor-beta1 as a regulator of the serpins/t-PA axis in cerebral ischemia.

Docagne F, Nicole O, Marti HH, MacKenzie ET, Buisson A, Vivien D.

FASEB J. 1999 Aug;13(11):1315-24.

PMID:
10428756
3.

Leptin suppresses anti-Mullerian hormone gene expression through the JAK2/STAT3 pathway in luteinized granulosa cells of women undergoing IVF.

Merhi Z, Buyuk E, Berger DS, Zapantis A, Israel DD, Chua S Jr, Jindal S.

Hum Reprod. 2013 Jun;28(6):1661-9. doi: 10.1093/humrep/det072. Epub 2013 Mar 15.

PMID:
23503941
4.

The brain-specific tissue-type plasminogen activator inhibitor, neuroserpin, protects neurons against excitotoxicity both in vitro and in vivo.

Lebeurrier N, Liot G, Lopez-Atalaya JP, Orset C, Fernandez-Monreal M, Sonderegger P, Ali C, Vivien D.

Mol Cell Neurosci. 2005 Dec;30(4):552-8. Epub 2005 Oct 4.

PMID:
16209928
5.

Neuroserpin, a brain-associated inhibitor of tissue plasminogen activator is localized primarily in neurons. Implications for the regulation of motor learning and neuronal survival.

Hastings GA, Coleman TA, Haudenschild CC, Stefansson S, Smith EP, Barthlow R, Cherry S, Sandkvist M, Lawrence DA.

J Biol Chem. 1997 Dec 26;272(52):33062-7.

6.

Neuroserpin protects neurons from ischemia-induced plasmin-mediated cell death independently of tissue-type plasminogen activator inhibition.

Wu J, Echeverry R, Guzman J, Yepes M.

Am J Pathol. 2010 Nov;177(5):2576-84. doi: 10.2353/ajpath.2010.100466. Epub 2010 Sep 23.

7.

Engagement of bone morphogenetic protein type IB receptor and Smad1 signaling by anti-Müllerian hormone and its type II receptor.

Gouédard L, Chen YG, Thevenet L, Racine C, Borie S, Lamarre I, Josso N, Massague J, di Clemente N.

J Biol Chem. 2000 Sep 8;275(36):27973-8.

8.

Neuroserpin is post-transcriptionally regulated by thyroid hormone.

Navarro-Yubero C, Cuadrado A, Sonderegger P, Muñoz A.

Brain Res Mol Brain Res. 2004 Apr 7;123(1-2):56-65.

PMID:
15046866
9.
10.

Deregulation of anti-Mullerian hormone/BMP and transforming growth factor-beta pathways in Leydig cell lesions developed in male heterozygous multiple endocrine neoplasia type 1 mutant mice.

Hussein N, Lu J, Casse H, Fontanière S, Morera AM, Guittot SM, Calender A, Di Clemente N, Zhang CX.

Endocr Relat Cancer. 2008 Mar;15(1):217-27. doi: 10.1677/ERC-06-0046.

11.

Natural mutations of the anti-Mullerian hormone type II receptor found in persistent Mullerian duct syndrome affect ligand binding, signal transduction and cellular transport.

Belville C, Maréchal JD, Pennetier S, Carmillo P, Masgrau L, Messika-Zeitoun L, Galey J, Machado G, Treton D, Gonzalès J, Picard JY, Josso N, Cate RL, di Clemente N.

Hum Mol Genet. 2009 Aug 15;18(16):3002-13. doi: 10.1093/hmg/ddp238. Epub 2009 May 20.

PMID:
19457927
12.

Anti-Müllerian hormone and its receptors.

Josso N, di Clemente N, Gouédard L.

Mol Cell Endocrinol. 2001 Jun 20;179(1-2):25-32. Review.

PMID:
11420127
13.

Neuronal depolarization enhances the transcription of the neuronal serine protease inhibitor neuroserpin.

Berger P, Kozlov SV, Cinelli P, Krüger SR, Vogt L, Sonderegger P.

Mol Cell Neurosci. 1999 Dec;14(6):455-67.

PMID:
10656253
14.

AMH signaling: from receptor to target gene.

Visser JA.

Mol Cell Endocrinol. 2003 Dec 15;211(1-2):65-73. Review.

PMID:
14656478
15.

Genetic studies of the AMH/MIS signaling pathway for Müllerian duct regression.

Jamin SP, Arango NA, Mishina Y, Hanks MC, Behringer RR.

Mol Cell Endocrinol. 2003 Dec 15;211(1-2):15-9.

PMID:
14656471
16.

Components of the anti-Müllerian hormone signaling pathway in gonads.

di Clemente N, Josso N, Gouédard L, Belville C.

Mol Cell Endocrinol. 2003 Dec 15;211(1-2):9-14. Review.

PMID:
14656470
17.

Transduction pathway of anti-Müllerian hormone, a sex-specific member of the TGF-beta family.

Josso N, Clemente Nd.

Trends Endocrinol Metab. 2003 Mar;14(2):91-7. Review.

PMID:
12591180
18.

Anti-Müllerian hormone recruits BMPR-IA in immature granulosa cells.

Sèdes L, Leclerc A, Moindjie H, Cate RL, Picard JY, di Clemente N, Jamin SP.

PLoS One. 2013 Nov 28;8(11):e81551. doi: 10.1371/journal.pone.0081551. eCollection 2013.

19.

The type 2 anti-Müllerian hormone receptor has splice variants that are dominant-negative inhibitors.

Imhoff FM, Yang D, Mathew SF, Clarkson AN, Kawagishi Y, Tate WP, Koishi K, McLennan IS.

FEBS Lett. 2013 Jun 19;587(12):1749-53. doi: 10.1016/j.febslet.2013.04.014. Epub 2013 Apr 25.

20.

Neuroserpin: a selective inhibitor of tissue-type plasminogen activator in the central nervous system.

Yepes M, Lawrence DA.

Thromb Haemost. 2004 Mar;91(3):457-64. Review.

PMID:
14983220

Supplemental Content

Support Center